Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million.

Property Value
dbo:abstract
  • Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million. (en)
dbo:foundingYear
  • 1984-01-01 (xsd:date)
dbo:industry
dbo:location
dbo:parentCompany
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 20421670 (xsd:integer)
dbo:wikiPageLength
  • 4003 (xsd:integer)
dbo:wikiPageRevisionID
  • 858737846 (xsd:integer)
dbp:foundation
  • 1984 (xsd:integer)
dbp:homepage
dbp:industry
dbp:location
  • Marlborough, Massachusetts, United States (en)
dbp:logo
  • File:Cynapsus Therapeutics logo.jpg (en)
dbp:name
  • Cynapsus Therapeutics Inc. (en)
dbp:parent
dbp:type
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Cynapsus Therapeutics Inc. is a specialty pharmaceutical company developing a drug to treat the motor symptoms of Parkinson's disease. Based in Toronto, Ontario, Canada. Formerly named Cannasat Therapeutics they changed their name to Cynapsus Therapeutics in 2010. In September 2016, Sunovion (a subsidiary of Dainippon Sumitomo Pharma) announced it would acquire Cynapsus Therapeutics for approximately $624 million. (en)
rdfs:label
  • Cynapsus Therapeutics (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Cynapsus Therapeutics Inc. (en)
is dbo:wikiPageRedirects of
is foaf:primaryTopic of